$NVAX approvals and orders locked in. Everything else is noise. Current market cap doesn’t reflect any reasonable revenue or earnings multiple for what’s approved and on order. It’s that simple. $Novavax(NVAX)$ these fast intraday rejections are the initial warnings, of the many more rejections to come, for a WHILE. Imo.
It's also a reminder not to start throwing ridiculous numbers around (300s, 500s, 2000, ya know?) and a stark reminder that NEWS means JACK, hereafter.
Buy the supps, sell on the spikes imo.
精彩评论